Pfizer’s R&D division works in partnership with hundreds of collaborators, including some of the world’s top researchers and scientists in academia, healthcare, government and the biopharmaceutical industry.
We’re working together in real time to find new ways to deploy our collaborative strengths to solve serious and complex medical challenges that no one group can solve alone.
Our focus is on the areas of greatest unmet medical need, where we apply more than 160 years of Pfizer expertise, leading science and cutting-edge technology platforms.
Pfizer is working to expedite programs that will help translate research into innovative therapies. We’ve recently expanded our Centers for Therapeutic Innovation open innovation network across biomedical hubs in the U.S. and are partnering with disease foundations to accelerate the development of therapies for patients.